PTCH1 mutation promotes antitumor immunity and the response to immune checkpoint inhibitors in colorectal cancer patients.
Wang Y, Chen H, Jiao X, Wu L, Yang Y, Zhang J, Wu L, Liu C, Zhuo N, Li S, Gong J, Li J, Zhang X, Wang X, Peng Z, Qi C, Wang Z, Li J, Li Y, Lu Z, Zhang H, Shen L.
Wang Y, et al. Among authors: chen h.
Cancer Immunol Immunother. 2022 Jan;71(1):111-120. doi: 10.1007/s00262-021-02966-9. Epub 2021 May 24.
Cancer Immunol Immunother. 2022.
PMID: 34028566
Free PMC article.